EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
120 hedge funds and large institutions have $1.08B invested in Eagle Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
12% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 26
75% less call options, than puts
Call options by funds: $1.36M | Put options by funds: $5.5M
Holders
120
Holding in Top 10
6
Calls
$1.36M
Puts
$5.5M
Top Buyers
| 1 | +$36.9M | |
| 2 | +$36.2M | |
| 3 | +$34.9M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$17.9M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$15.9M |
Top Sellers
| 1 | -$33.7M | |
| 2 | -$31.3M | |
| 3 | -$13.9M | |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$9.81M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$6.24M |